Annual Non Current Assets
$16.42 B
+$1.31 B+8.69%
December 31, 2024
Summary
- As of March 14, 2025, RPRX annual long term assets is $16.42 billion, with the most recent change of +$1.31 billion (+8.69%) on December 31, 2024.
- During the last 3 years, RPRX annual non current assets has risen by +$1.78 billion (+12.18%).
- RPRX annual non current assets is now at all-time high.
Performance
RPRX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$16.42 B
+$172.53 M+1.06%
December 31, 2024
Summary
- As of March 14, 2025, RPRX quarterly long term assets is $16.42 billion, with the most recent change of +$172.53 million (+1.06%) on December 31, 2024.
- Over the past year, RPRX quarterly non current assets has increased by +$1.31 billion (+8.69%).
- RPRX quarterly non current assets is now at all-time high.
Performance
RPRX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
RPRX Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.7% | +8.7% |
| 3 y3 years | +12.2% | +8.7% |
| 5 y5 years | +41.3% | +8.7% |
RPRX Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +15.2% | at high | +16.2% |
| 5 y | 5-year | at high | +41.3% | at high | +41.3% |
| alltime | all time | at high | +87.4% | at high | +41.3% |
Royalty Pharma Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $1.80 B(+41.4%) | $16.42 B(+1.1%) |
| Sep 2024 | - | $16.25 B(+7.8%) |
| Jun 2024 | - | $15.08 B(+3.5%) |
| Mar 2024 | - | $14.57 B(-3.6%) |
| Dec 2023 | $1.27 B(-50.1%) | $15.11 B(+6.9%) |
| Sep 2023 | - | $14.13 B(-0.3%) |
| Jun 2023 | - | $14.17 B(-1.9%) |
| Mar 2023 | - | $14.44 B(+1.3%) |
| Dec 2022 | $2.55 B | $14.26 B(-7.0%) |
| Sep 2022 | - | $15.33 B(+7.7%) |
| Jun 2022 | - | $14.24 B(-1.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $14.40 B(-1.6%) |
| Dec 2021 | $2.88 B(+6.7%) | $14.64 B(-2.1%) |
| Sep 2021 | - | $14.96 B(+8.3%) |
| Jun 2021 | - | $13.81 B(+2.3%) |
| Mar 2021 | - | $13.50 B(+1.3%) |
| Dec 2020 | $2.70 B(+224.1%) | $13.32 B(+0.9%) |
| Sep 2020 | - | $13.21 B(+7.4%) |
| Jun 2020 | - | $12.29 B(+5.7%) |
| Mar 2020 | - | $11.63 B(+0.1%) |
| Dec 2019 | $832.07 M(-68.1%) | $11.62 B |
| Dec 2018 | $2.61 B | - |
FAQ
- What is Royalty Pharma annual long term assets?
- What is the all time high annual non current assets for Royalty Pharma?
- What is Royalty Pharma annual non current assets year-on-year change?
- What is Royalty Pharma quarterly long term assets?
- What is the all time high quarterly non current assets for Royalty Pharma?
- What is Royalty Pharma quarterly non current assets year-on-year change?
What is Royalty Pharma annual long term assets?
The current annual non current assets of RPRX is $16.42 B
What is the all time high annual non current assets for Royalty Pharma?
Royalty Pharma all-time high annual long term assets is $16.42 B
What is Royalty Pharma annual non current assets year-on-year change?
Over the past year, RPRX annual long term assets has changed by +$1.31 B (+8.69%)
What is Royalty Pharma quarterly long term assets?
The current quarterly non current assets of RPRX is $16.42 B
What is the all time high quarterly non current assets for Royalty Pharma?
Royalty Pharma all-time high quarterly long term assets is $16.42 B
What is Royalty Pharma quarterly non current assets year-on-year change?
Over the past year, RPRX quarterly long term assets has changed by +$1.31 B (+8.69%)